Phase 2 clinical trials
Updates to Article Attributes
Body
was changed:
Phase 2 clinical trials occur after a drug (or treatment) has successfully passed both Phase 0 and Phase 1 trials. Phase 2 clinical trials are performed on larger number individuals (e.g. ~200) and aim to identify whether or not it is effective. Additional data on safety and side-effects is also obtained. It forms the basis for the much larger Phase 3 trials.
-<p><span style="font-size:13px; line-height:1.6em"><strong>Phase 2 clinical trials</strong> occur after a drug (or treatment) has successfully passed both <a title="Phase 0 clinical trials" href="/articles/phase-0-clinical-trials">Phase 0</a> and <a title="Phase 1 clinical trials" href="/articles/phase-1-clinical-trials">Phase 1</a> trials. Phase 2 clinical trials are performed on larger number individuals (e.g. ~200) and aim to identify whether or not it is effective. Additional data on safety and side-effects is also obtained. It forms the basis for the much larger <a title="Phase 3 clinical trials" href="/articles/phase-3-clinical-trials">Phase 3</a> trials. </span></p><p> </p>- +<p><strong>Phase 2 clinical trials</strong> occur after a drug (or treatment) has successfully passed both <a href="/articles/phase-0-clinical-trials">Phase 0</a> and <a href="/articles/phase-1-clinical-trials">Phase 1</a> trials. Phase 2 clinical trials are performed on larger number individuals (e.g. ~200) and aim to identify whether or not it is effective. Additional data on safety and side-effects is also obtained. It forms the basis for the much larger <a href="/articles/phase-3-clinical-trials">Phase 3</a> trials. </p><p> </p>